CLASS.AUTOMAITE.CA

Pfizer Settles Oxbryta Lawsuit Over Child’s Vaso-Occlusive Crises (VOCs) Linked To Recalled Drug

Open

As of 2026-06-24, the Pfizer Settles Oxbryta Lawsuit Over Child’s Vaso-Occlusive Crises (VOCs) Linked To Recalled Drug is open. You can check whether you qualify with the free 1-minute eligibility self-check below.

Key facts — Pfizer Settles Oxbryta Lawsuit Over Child’s Vaso-Occlusive Crises (VOCs) Linked To Recalled Drug
CasePfizer Settles Oxbryta Lawsuit Over Child’s Vaso-Occlusive Crises (VOCs) Linked To Recalled Drug
StatusOpen
Law firmAbout Lawsuits
JurisdictionUSA
Filing deadlineSee case details

Last verified: 2026-06-24

Am I eligible for the Pfizer Settles Oxbryta Lawsuit Over Child’s Vaso-Occlusive Crises (VOCs) Linked To Recalled Drug?

Oxbryta’s manufacturers say they have reached a proposed settlement to resolve a lawsuit filed by a mother whose child was hospitalized with VOCs, the same painful sickle cell complications the drug was intended to prevent.

Check if you qualify →

How do I join the Pfizer Settles Oxbryta Lawsuit Over Child’s Vaso-Occlusive Crises (VOCs) Linked To Recalled Drug?

  1. Run the free 1-minute eligibility self-check.
  2. If you qualify, register your claim on the platform.
  3. Class members typically pay nothing unless money is recovered.

Other active class actions

← Browse all 3196+ class actions

This is a free eligibility self-check, not a law firm, not legal advice, and not a lawyer referral service. Using it does not create a lawyer-client relationship.